MedTrace Logo

Coronary Artery Revascularization in Diabetes

NCT00326196 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 198

Last updated 2014-04-25

Study results available
· View outcomes & findings →

Summary

This is a randomized, multi-site, clinical trial comparing percutaneous coronary stenting (PCI) with drug eluding stents to coronary bypass for angiographically significant coronary artery disease in diabetes. The hypothesis being tested is that a strategy of surgical revascularization is superior to percutaneous intervention in preventing death or myocardial infarction in diabetics with severe ischemic heart disease.

Conditions

Interventions

DEVICE

Percutaneous coronary intervention (PCI)

percutaneous coronary stenting with drug eluding stents

PROCEDURE

Coronary artery bypass graft (CABG)

coronary bypass

Sponsors & Collaborators

Principal Investigators

  • Masoor Kamalesh, MD · Richard Roudebush VA Medical Center, Indianapolis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00326196 on ClinicalTrials.gov